Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00920985 · ClinicalTrials.gov registry record · Phase 3
US Cycle Control and Blood Pressure Study
A Phase 3 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 346
- Enrollment target
NCT00920985 is a Phase 3 study that has completed, run by Bayer. The registered enrollment target is 346 participants.
The verdict
NCT00920985, a Phase 3 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 346 participants
- Enrollment target
Study Summary
Birth Control Patch Study
Interventions
- DRUG Gestodene/EE (FC Patch Low, BAY86-5016)
- DRUG Oral contraceptive (equivalent to the active treatment tablets of Levlite), 21-day blister SH D00593A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 346 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00920985
The ClinicalTrials.gov registry entry for NCT00920985 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 346 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gestodene/EE (FC Patch Low, BAY86-5016) is the first listed.
NCT00920985 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00920985 about?
NCT00920985 is a clinical study titled "US Cycle Control and Blood Pressure Study". Birth Control Patch Study
What is the current status of trial NCT00920985?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 346 participants. The study started on 2009-06. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00920985?
The interventions under investigation include: Gestodene/EE (FC Patch Low, BAY86-5016) (DRUG), Oral contraceptive (equivalent to the active treatment tablets of Levlite), 21-day blister SH D00593A (DRUG).
Who is sponsoring clinical trial NCT00920985?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.